Claus Crone Fuglsang

Claus Crone Fuglsang is CSO and Executive Vice President of Research & Development at Novozymes, responsible for Enzyme Research, Microbe Research, Product & Process Development, Regulatory Affairs and Product Safety, Intellectual Property & Licensing and R&D Portfolio & Projects. The Research & Development function is the foundation for finding biological solutions for better lives.

Since joining Novozymes in 1993, Claus has been in several leadership roles in R&D in both Denmark and the US. Prior to his current position, he spent over four years as one of only two Senior Vice Presidents in the company, responsible for driving Novozymes’ core research and technology development.

Claus has a Master’s degree in Biochemistry from the University of Copenhagen and an MBA from Heriot-Watt University, Edinburgh Business School.